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T
 
HE
 
 execution phase is the “active” phase of apopto-
sis occurring immediately after a cell commits to the
death program. It lasts about an hour and is charac-
terized by the hallmark morphologic features of apoptosis
(e.g., membrane blebbing, chromatin condensation, and
DNA fragmentation) culminating with disassembly and
packaging of the cell for phagocytosis. Most studies of the
execution phase have focused on elucidating nuclear
events with the identification of important mechanisms re-
sponsible for nuclear execution such as the link between
release of cytochrome c, activation of caspase 9/3, and
DNA fragmentation (Li et al., 1997; Liu et al., 1997; Enari
et al., 1998). Study of cytoplasmic or extranuclear events,
on the other hand, has lagged. However, within the past
two years, insights into underlying mechanisms and bio-
chemical regulation have led to greatly increased interest
in execution phase events occurring outside the nucleus.
Despite the recent interest in the extranuclear execution
phase, there has been no previous review of the literature,
and, at first glance, the various studies appear relatively
disparate. However, by subdividing the execution phase
into three sequential phases, almost all the data obtained
on extranuclear execution phase events can be organized
into a relatively coherent paradigm (Fig. 1). In the model
we propose, the first stage is release. As most cells enter
the execution phase, they release extracellular matrix
(ECM)
 
1
 
 attachments and reorganize focal adhesions (FA),
adopting a more “rounded” morphology. This outward
change correlates with loss of stress fibers (if present) and
a reorganization of actin into a peripheral (cortical), mem-
brane-associated ring. Microtubule disassembly also oc-
curs in this stage. The blebbing stage begins with myosin
 
II–dependent
 
 
 
contraction of the actin ring followed by a
period of sustained, dynamic plasma membrane protru-
sion and retraction. It continues until finally the cell enters
the condensation stage, which is characterized by con-
densation into small apoptotic bodies or into a single,
shrunken ball, correlating with dissolution of polymerized
actin. This article will review advances in extranuclear exe-
cution phase events within the context of these stages. The
goal of the proposed organizational scheme is not to be
all-inclusive but, rather, to offer a temporal and structural
framework within which nonnuclear execution phase
events can be classified.
 
Release (Actin Reorganization)
 
The first step in most cells undergoing apoptosis is to par-
tially detach from the ECM and “round up.” The process
is most dramatic in cells that are spread out, with firm ma-
trix attachments and stress fibers, such as fibroblasts,
epithelial, and endothelial cells (Brancolini et al., 1997;
Levkau et al., 1998; Huot et al., 1998). The process is least
pronounced in cells with weak ECM attachments, such as
lymphocytes. The release stage has been partially eluci-
dated in endothelial cells, wherein strong peripheral–lat-
eral FA complexes disassemble with reconcentration of
focal adhesion complexes ventrally underneath the newly
rounded cell body (Bannerman et al., 1998; Huot et al.,
1998; Levkau et al., 1998). Concomitantly, actin rearranges
into a peripheral ring in preparation for blebbing. Inhibit-
ing actin polymerization with low concentrations of cy-
tochalasin D maintains the spread state in the face of an
apoptotic stimulus, suggesting that actin rearrangement is
critical (Huot et al., 1998). Anoikis (apoptosis due to ECM
detachment) represents direct entry into the Release
stage. In anoikic cells, FA kinase (FAK) signaling is dis-
rupted (Frisch et al., 1996), leading to changes in a variety
of key signal transduction pathways (e.g., Ilic et al., 1998).
 
Key Cytoskeletal Proteins
 
FA Proteins. 
 
Intracellularly, FAK is cleaved, as are three
other FA structural proteins (
 
a
 
-actinin, talin, and p130-
CAS) that link actin to focal adhesions (Wen et al., 1997;
Bannerman et al., 1998; Levkau et al., 1998; van de Water
et al., 1999). Paxillin, another structural FA protein, is de-
phosphorylated and dissociates from the FA (Bannerman
et al., 1998).
 
Actin Regulators. 
 
hsp27, which mediates actin reorgani-
zation, is critical for actin rearrangement in apoptosis of
 
endothelial cells (Huot et al., 1998). Gelsolin is also
 
 
 
impli-
cated in this phase based on studies with gelsolin 
 
2/2
 
 cells
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showing significant delay in onset of blebbing, though
blebbing eventually occurs (Kothakota et al., 1997).
 
Microtubules. 
 
Microtubule (MT) disassembly occurs early
in the execution phase and may be necessary for cells to
round up (Mills et al., 1998a). Besides crippling intracellu-
lar transport, disassembly of MTs alters cellular compart-
ments and releases a number of regulatory proteins that
are normally bound to MTs (e.g., Reszka et al., 1997; Mills
et al., 1998a; Nagata et al., 1998).
 
Effectors
 
Proteases. 
 
Caspases are implicated in this phase, as many
cell types do not begin morphological manifestations of
the execution phase if caspases are inhibited (however,
this may occur predominately in systems where signal
transduction of the apoptotic stimuli requires upstream
caspases). Caspases cleave FA proteins including FAK
and p130CAS (Bannerman et al., 1998; Levkau et al.,
1998). However, many cell types retract and/or begin
blebbing despite caspase inhibition (McCarthy et al., 1997;
Mills et al., 1998b; Huot et al., 1998). Calpains, which
cleave 
 
a
 
-actinin, fodrin, and talin (structural proteins
linking actin and the plasma membrane) are also impli-
cated in release (Knepper-Nicolai et al., 1998; Wang et al.,
1998).
 
Kinases. 
 
p38MAP kinase signaling activates hsp27 and ac-
tin reorganization (Huot et al., 1998). In anoikis, MEKK-1,
an upstream regulator of p38MAP kinase, is activated by
caspases and may in turn play a role in caspase-7 activation
(Cardone et al., 1997); this potential positive feedback
loop may explain why entry into the execution phase is ap-
parently irreversible. The p21-activated kinase 2 (Pak2),
which is activated by the small GTPases, Rac and Cdc42,
and is known to reorganize the actin cytoskeleton, is
cleaved into an active form by caspases (Lee et al., 1997;
Rudel and Bokoch, 1997). In nondying cells, a different
family member, Pak1, causes stress fiber disassembly and
retraction by phosphorylating myosin light chain kinase
(MLCK), and decreasing myosin activation (Sanders et al.,
1999). Thus, Pak1 could be important for stress fiber dis-
assembly and, indirectly, actin reorganization (see also
below).
 
Blebbing (Actin–Myosin II Contraction)
 
After the cell rounding up that occurs during release, the
model we propose involves myosin II activation centripe-
 
tally contracting the cortical actin ring. At the same time,
membrane-actin linkages weaken focally, resulting in bleb
extrusion in areas of weakness (Fig. 2). A counterforce
(perhaps myosin I or VI) retracts the blebs and the cycle
repeats. Actin and myosin may concentrate at the base of
blebs, and a thin rim of membrane-associated actin lines
the blebs. Blebbing does not occur in some cells lacking
caspase 3 (Janicke et al., 1998; Zheng et al., 1998); cells ap-
pear to release but do not bleb (Pittman, R., unpublished
observations), suggesting a cellular checkpoint exists be-
tween release and blebbing.
 
Key Cytoskeletal Proteins
 
Myosins. 
 
Myosin II, or conventional myosin, seems to pro-
vide the force for dynamic membrane blebbing in both
apoptotic and nonapoptotic systems (Mills et al., 1998b;
Torgerson and McNiven, 1998). Inhibition of myosin mo-
tor activity or the myosin activators MLCK or RhoA stops
bleb formation in apoptotic cells (Mills et al., 1998b). A
role for nonconventional myosins is based on the fact that
the general myosin motor inhibitor butanedione mon-
oxime (BDM) inhibits bleb retraction (Mills et al., 1998b)
and based on the role nonconventional myosins like myo-
sin I and VI have in regulating protrusive membrane struc-
tures in general (for example see Mitchison and Cramer,
1996).
 
Actin. 
 
Disruption of the actin cytoskeleton with cyto-
chalasin D decreases membrane blebbing (Mills et al.,
1998b), implying that actin polymerization and/or poly-
merized actin are needed for force generation.
 
Actin-membrane Linking Proteins. 
 
The links these pro-
teins provide between the actin cytoskeleton and the
plasma membrane may be broken focally, allowing blebs
to protrude at foci where the plasma membrane is no
longer anchored to the cytoskeleton. Fodrin (nonerythro-
cyte spectrin) has been implicated in blebbing numerous
times, as it is readily cleaved in multiple places by caspases
and calpains (Martin et al., 1995; Cryns et al., 1996; Nath
et al., 1996; Wang et al., 1998). The ezrin, moesin, radixin
family of actin membrane–linking proteins is also dephos-
phorylated and dissociates from the membrane during the
execution phase (Kondo et al., 1997), and ezrin can be
cleaved by calpains (Knepper-Nicolai et al., 1998).
 
Effectors
 
Proteases. 
 
Although caspases cleave cytoskeletal compo-
Figure 1. Scheme for tem-
poral and mechanistic organ-
ization of the cytoplasmic
execution phase. (Top) Mor-
phological view. (Bottom)
Corresponding actin rear-
rangements. 
Mills et al. 
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nents like fodrin and, therefore, have been implicated in
this stage, many cells bleb for days with caspases appar-
ently inhibited (McCarthy et al., 1997; Mills et al., 1998b).
 
Myosin Activators. 
 
MLCK, which activates nonmuscle
myosin II by phosphorylating the regulatory light chain, is
necessary for initiation and propagation of blebbing (Mills
et al., 1998b; Torgerson and McNiven, 1998).
 
 
 
RhoA has
also been shown to be important for blebbing (Mills et al.,
1998b), probably by activating Rho kinase, which phos-
phorylates and inhibits myosin phosphatase (Noda et al.,
1995; Kimura et al., 1996).
 
Miscellaneous. 
 
Large amounts of ATP are required for
blebbing (to maintain myosin contractility), so cellular en-
ergy generation most likely is not compromised (Nicotera
and Leist, 1997; Tsujimoto, 1997).
 
Condensation (Actin Dissolution)
 
All cells eventually stop blebbing. Under normal condi-
tions, this usually happens with striking regularity after
about an hour. Cessation of blebbing is followed by frag-
mentation into small apoptotic bodies or condensation
into a small ball with actin and MTs largely disassembled
 
or degraded (Mills et al., 1998a). The Condensation Stage
may simply represent the end result of blebbing, when
contraction occurs strongly enough to pinch off apoptotic
bodies. However, caspase inhibition can stop apoptotic
body formation without stopping blebbing (McCarthy et al.,
1997; Hirata et al., 1998). Hence, apoptotic body forma-
tion, although a direct offshoot of blebbing, must repre-
sent a distinct stage of the execution phase, immediately
downstream of blebbing. There may be a cellular check-
point between blebbing and condensation, or perhaps cells
can condense only after enough cytoskeleton has been dis-
mantled/reorganized to allow cytoplasmic dissolution.
 
Key Cytoskeletal Players
 
Little is known about specific, regulatable aspects of this
final active stage of apoptosis; however, F-actin seems to
be required for apoptotic body formation (Cotter et al.,
1992).
 
Effectors
 
Proteases. 
 
Caspases almost certainly play a role, as inhibi-
tion of caspases leads to either no morphologic changes
Figure 2. Model for bleb ex-
trusion. Contraction of corti-
cal actin filaments by myosin
II causes contraction of
plasma membrane, except in
focal regions of weakness in
actin links to the membrane.
Such regions of weakness can
be caused by cleavage of
membrane-anchoring pro-
teins (e.g., fodrin). The com-
bination of contraction and
focal loss of membrane sup-
port leads to bleb formation. 
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during apoptosis or leads to cells trapped in a blebbing
state, unable to condense (McCarthy et al., 1997; Hirata
et al., 1998; Huot et al., 1998; Mills et al., 1998b). Perhaps
the role of caspases in cell shrinkage events is merely to
limit blebbing and induce condensation. This might hap-
pen by caspases slowly degrading proteins necessary for
blebbing (e.g., actin). Other proteases might also be im-
portant (e.g., serine proteases and proteasomal proteases).
 
Paks. 
 
The p21-activated kinase Pak1 appears critical for
apoptotic body formation (Rudel and Bokoch, 1997).
 
Transglutaminase. 
 
In some cells, activation of the pro-
tein cross-linking enzyme, transglutaminase, has been im-
plicated in cytoplasmic packaging during condensation
(Fesus, 1993).
 
Roles of the Extranuclear Execution Phase
 
Apoptosis is known to be a broadly conserved means of
eliminating cells without damaging neighboring cells, with-
out spreading pathogenic DNA, and without inciting an
immune response. It is during the execution phase that
these evolutionary directives are carried out. However, it
is not yet understood exactly which events in the execution
phase correlate with the evolutionarily driven functions of
apoptosis. For example, although blebbing is an almost
universal feature of apoptosis, it is not clear why cells bleb.
Perhaps, cytoplasmic blebs represent a mechanostructural
communication to neighboring cells to begin the process
of phagocytosis, or maybe membrane blebbing functions
within the dying cell to deplete ATP, to mix compartments
as part of cellular packaging, or as a prerequisite for apop-
totic body formation. In any case, the release, retraction,
and condensation stages culminate with the creation of a
smaller cell or cell fragments for facilitated phagocytic
clearance. For cells that maintain strong cell–cell contacts
(such as epithelial or endothelial cells), the cytoplasmic ex-
ecution phase machinery may be very important for an-
other reason. The contraction of an apoptotic cell may be
an altruistic means of preserving an intact monolayer, as
the dying cell expends its energy contracting neighboring
cells to cover the potential gap that would be created by
the dying cell (Fig. 3). In epithelial monolayers the execu-
tion phase of a cell results in stretching of neighboring
cells toward the dying cell (Nagai and Kalnins, 1996; Soler
et al., 1996). Stress fibers form in the neighbors, suggesting
that they are being pulled rather than locomoting them-
selves. The dying cell likely generates force by the same
mechanism underlying membrane blebbing (actin-myosin
contractions); therefore, inhibiting blebbing and/or con-
densation phases should decrease barrier function in epi-
thelia.
In conclusion, from the standpoint of the organism, the
most important aspect of apoptosis is that death occurs
without the release of potentially pathogenic or harmful
macromolecules and without inflammation or injury to
neighboring cells. A primary role of the execution phase is
to insure that the dying cell is packaged to avoid these po-
tentially devastating sequelae. The past two years have
been marked by considerable increase in basic informa-
tion on mechanisms underlying the extranuclear execution
phase. While it is still too early to generate a precise model
or scheme of this critical aspect of apoptosis, it is possible
to organize most of the results as they pertain to three dis-
tinct stages: release, blebbing, and condensation. It is be-
coming clear that these stages represent specific, inhib-
itable underlying processes with evolutionarily important
roles. Given the recent flurry of information, it appears
that research on the extranuclear execution phase is now
primed to advance our fundamental understanding of apop-
tosis into uncharted areas. Besides the obvious impact of
this area of work for understanding the apoptotic process,
an additional benefit of investigation into cytoplasmic exe-
cution should be a better understanding of the cytoskele-
ton in general with
 
 
 
potential novel roles for microtubules,
actin, and myosin.
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